Inconstant results were observed in clinical trials using intracerebral GT for other lysosomal diseases (MPSIIIA, MPSIIIB, LINCL) (Tardieu et al., 2014, 2017; Sondhi et al., 2020). Here, NAGLU is linked to late infantile neuronal ceroid lipofuscinosis.